Listen for Patients on Hep C Meds Reporting Serious Liver Problems

April 2017

You'll hear about a link between hepatitis C meds and liver damage...especially in patients who also have hepatitis B.

FDA now requires a boxed warning about the risk of hepatitis B reactivation with newer hep C meds...Epclusa, Harvoni, Zepatier, etc.

And a recent report from Institute for Safe Medication Practices warns about rare cases of liver injury and failure tied to these meds.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Pharmacy Technicians Be Ready for New Opportunities as Your Role Continues to Expand
Topicals Understand How Topical Dosage Forms Differ
Constipation Think of Trulance as Similar to Linzess or Amitiza for Constipation
Inhalers Ellipta Is the Name of the Inhalation Device...NOT the Med
Gastroenterology Send Parents With Concerns About Miralax's Neuropsych Effects to the Pharmacist
Geriatrics Take Steps to Help Seniors Prevent Falls
Hepatitis C Listen for Patients on Hep C Meds Reporting Serious Liver Problems
Neurology & Pain Help Sort Through Meds for Restless Legs Syndrome
Women's Health Document Whether New Moms With Postpartum Depression Are Breastfeeding
Asthma Watch for Rxs That Reduce or Stop Asthma Meds in Adults
Neuromuscular Be Familiar With the Meds Used to Treat Hiccups